# ATRA, Celecoxib, and Itraconazole as Maintenance

> **NCT02401295** · PHASE1 · COMPLETED · sponsor: **University of Iowa** · enrollment: 1 (actual)

## Conditions studied

- Relapsed Multiple Myeloma

## Interventions

- **DRUG:** ATRA
- **DRUG:** Celecoxib
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT02401295
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-08
- **Final completion:** 2016-11
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02401295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02401295, "ATRA, Celecoxib, and Itraconazole as Maintenance". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02401295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*